Key statistics
On Friday, Elicio Therapeutics Inc (ELTX:NAQ) closed at 5.00, 68.92% above the 52 week low of 2.96 set on Feb 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.00 |
---|---|
High | 5.06 |
Low | 4.88 |
Bid | 4.95 |
Offer | 5.07 |
Previous close | 4.87 |
Average volume | 22.18k |
---|---|
Shares outstanding | 10.77m |
Free float | 7.74m |
P/E (TTM) | -- |
Market cap | 52.47m USD |
EPS (TTM) | -4.83 USD |
Data delayed at least 15 minutes, as of Sep 27 2024 20:57 BST.
More ▼
- Elicio Therapeutics Reports Inducement Grants
- Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
- Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
- Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
- Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
- Elicio Therapeutics Announces Proposed Public Offering
- Elicio Therapeutics Announces Preliminary Disease-Free Survival analysis from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P
- Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
More ▼